Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children
暂无分享,去创建一个
Thomas A. Smith | N. Maire | L. Conteh | A. Ross | E. Sicuri
[1] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[2] M. Hanlon,et al. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data. , 2013, International health.
[3] L. Conteh,et al. Coverage, Adherence and Costs of Intermittent Preventive Treatment of Malaria in Children Employing Different Delivery Strategies in Jasikan, Ghana , 2011, PloS one.
[4] D. Chandramohan,et al. The clinical impact of combining intermittent preventive treatment with home management of malaria in children aged below 5 years: cluster randomised trial , 2011, Tropical medicine & international health : TM & IH.
[5] Anne L. Wilson. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intermittent Preventive Treatment of Malaria in Children (IPTc) , 2011, PloS one.
[6] D. Conway,et al. Two Strategies for the Delivery of IPTc in an Area of Seasonal Malaria Transmission in The Gambia: A Randomised Controlled Trial , 2011, PLoS medicine.
[7] A. Dicko,et al. Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.
[8] I. Mueller,et al. Intermittent Preventive Treatment to Reduce the Burden of Malaria in Children: New Evidence on Integration and Delivery , 2011, PLoS medicine.
[9] S. Cousens,et al. Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.
[10] K. Bojang,et al. A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia , 2011, Malaria Journal.
[11] R. Legood,et al. Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children , 2010, PloS one.
[12] D. Conway,et al. A Randomised Trial to Compare the Safety, Tolerability and Efficacy of Three Drug Combinations for Intermittent Preventive Treatment in Children , 2010, PloS one.
[13] M. Tanner,et al. The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa , 2010, PloS one.
[14] J. Vinetz. Intermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention? , 2010, The American journal of tropical medicine and hygiene.
[15] K. Lindblade,et al. Intermittent Preventive Treatment in Infants for the Prevention of Malaria in Rural Western Kenya: A Randomized, Double-Blind Placebo-Controlled Trial , 2010, PloS one.
[16] M. Tanner,et al. Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis , 2010, PloS one.
[17] M. Chopra,et al. Implementing intermittent preventive treatment in infants , 2010, The Lancet.
[18] D. Chandramohan,et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[19] R. McGready. Intermittent preventive treatment of malaria in infancy , 2009, The Lancet.
[20] Pedro Alonso,et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials , 2009, The Lancet.
[21] D. Chandramohan,et al. Options for the Delivery of Intermittent Preventive Treatment for Malaria to Children: A Community Randomised Trial , 2009, PloS one.
[22] B. Cissé,et al. Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children , 2009, PloS one.
[23] M. Gomes,et al. The Impact of IPTi and IPTc Interventions on Malaria Clinical Burden – In Silico Perspectives , 2009, PloS one.
[24] O. Doumbo,et al. Intermittent preventive treatment using artemisinin‐based combination therapy reduces malaria morbidity among school‐aged children in Mali , 2009, Tropical medicine & international health : TM & IH.
[25] Fabrizio Tediosi,et al. Simulation of the cost-effectiveness of malaria vaccines , 2009, Malaria Journal.
[26] M. Tanner,et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. , 2009, Bulletin of the World Health Organization.
[27] F. Binka,et al. Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial , 2008, PloS one.
[28] B. Sharp,et al. Malaria Journal BioMed Central Research Costs and consequences of large-scale vector control for malaria , 2022 .
[29] L. Rénia,et al. Intermittent preventive antimalarial treatment to children (IPTc): firebreak or fire trap? , 2008, Trends in parasitology.
[30] S. Brooker,et al. Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya , 2008, Malaria Journal.
[31] Nicolas Maire,et al. What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines , 2008, PloS one.
[32] M. Tanner,et al. Towards a comprehensive simulation model of malaria epidemiology and control , 2008, Parasitology.
[33] M. Tanner,et al. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control , 2008, BMC health services research.
[34] Amanda Ross,et al. Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants , 2008, PloS one.
[35] S. Brooker,et al. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[36] O. Toure,et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali , 2008, Malaria Journal.
[37] S. Donegan,et al. Chemoprophylaxis and intermittent treatment for preventing malaria in children. , 2008, The Cochrane database of systematic reviews.
[38] A. Ghani,et al. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? , 2008, Malaria Journal.
[39] B. Cissé,et al. A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children , 2008, PloS one.
[40] R. Newman,et al. Intermittent preventive therapy for malaria: progress and future directions , 2007, Current opinion in infectious diseases.
[41] S. Agnandji,et al. Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. , 2007, The Journal of infectious diseases.
[42] W. Deressa,et al. Economic costs of epidemic malaria to households in rural Ethiopia , 2007, Tropical medicine & international health : TM & IH.
[43] F. Binka,et al. Assessing malaria control in the Kassena-Nankana district of northern Ghana through repeated surveys using the RBM tools , 2007, Malaria Journal.
[44] Awash Teklehaimanot,et al. Estimated global resources needed to attain international malaria control goals. , 2007, Bulletin of the World Health Organization.
[45] K. Reither,et al. Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana , 2007, Antimicrobial Agents and Chemotherapy.
[46] S. Adjei,et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] M. Tanner,et al. Age Interactions in the Development of Naturally Acquired Immunity to Plasmodium falciparum and Its Clinical Presentation , 2007, PLoS Medicine.
[48] S. Owusu-Agyei,et al. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? , 2007, Tropical medicine & international health : TM & IH.
[49] P. Fine,et al. Editorial: ‘Non‐specific effects of vaccines’– an important analytical insight, and call for a workshop , 2006, Tropical medicine & international health : TM & IH.
[50] Amanda Ross,et al. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[51] Thomas A. Smith,et al. The effect of malaria transmission intensity on neonatal mortality in endemic areas. , 2006, The American journal of tropical medicine and hygiene.
[52] Amanda Ross,et al. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.
[53] C. Menéndez,et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. , 2006, The Journal of infectious diseases.
[54] Amanda Ross,et al. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. , 2006, The American journal of tropical medicine and hygiene.
[55] Amanda Ross,et al. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. , 2006, The American journal of tropical medicine and hygiene.
[56] Thomas A. Smith,et al. Infectiousness of malaria-endemic human populations to vectors. , 2006, The American journal of tropical medicine and hygiene.
[57] Penelope Vounatsou,et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.
[58] Gerry Killeen,et al. Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[59] Thomas A. Smith,et al. Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania. , 2006, The American journal of tropical medicine and hygiene.
[60] Thomas A. Smith,et al. An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa. , 2006, The American journal of tropical medicine and hygiene.
[61] B. Greenwood. Review: Intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmission , 2006, Tropical medicine & international health : TM & IH.
[62] Alan D. Lopez,et al. Global burden of disease and risk factors , 2006 .
[63] L. Conteh,et al. Malaria prevention in The Gambia: patterns of expenditure and determinants of demand at the household level , 2006, Tropical medicine & international health : TM & IH.
[64] B. Cissé,et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial , 2006, The Lancet.
[65] W. Watkins,et al. Tolerance is the key to understanding antimalarial drug resistance. , 2006, Trends in parasitology.
[66] S. Jaffar,et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana , 2005, BMJ : British Medical Journal.
[67] J. Breman,et al. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi) , 2005, Malaria Journal.
[68] L. Kapiriri,et al. Can the value choices in DALYs influence global priority-setting? , 2004, Health policy.
[69] J. Sachs. Macroeconomics and health: investing in health for economic development , 2002 .
[70] J. Fox-Rushby,et al. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. , 2001, Health policy and planning.
[71] M. Tanner,et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial , 2001, The Lancet.
[72] E. Nord,et al. The value of DALY life: problems with ethics and validity of disability adjusted life years. , 2000, Leprosy review.
[73] D. Fontenille,et al. La transmission du paludisme dans la zone de Niakhar, Sénégal , 1998 .
[74] S. Anand,et al. Disability-adjusted life years: a critical review. , 1997, Journal of health economics.
[75] J. Dzator,et al. Household cost of seeking malaria care. A retrospective study of two districts in Ghana. , 1997, Social science & medicine.
[76] M. Weinstein,et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.
[77] C. Rogier,et al. Combating malaria morbidity and mortality by reducing transmission. , 1996, Parasitology today.
[78] A. Breckenridge,et al. The disposition of amodiaquine in Zambians and Nigerians with malaria. , 1990, British journal of clinical pharmacology.
[79] A. Mills,et al. Cost Effectiveness in Low- and Middle-Income Countries , 2012, PharmacoEconomics.
[80] J. Utzinger,et al. In a randomized controlled trial of iron fortification, anthelmintic treatment, and intermittent preventive treatment of malaria for anemia control in Ivorian children, only anthelmintic treatment shows modest benefit. , 2010, The Journal of nutrition.
[81] M. Tanner,et al. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[82] Boyce,et al. Pharmacokinetics and Disposition , 2007 .
[83] Alan D. Lopez,et al. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates -- Global Burden of Disease and Risk Factors , 2006 .
[84] P. Garner,et al. Chemoprophylaxis and intermittent treatment for preventing malaria in children. , 2005, The Cochrane database of systematic reviews.
[85] Weltgesundheitsorganisation. World malaria report , 2005 .
[86] J. Bras,et al. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis againstPlasmodium falciparum malaria , 2004, European Journal of Clinical Pharmacology.
[87] A. Mills,et al. Economic analysis of malaria control in Sub-Saharan Africa , 2000 .
[88] J. Murray,et al. The Global Burden of Disease , 1996 .